Variation in Human Papillomavirus Vaccine Uptake and Acceptability Between Female and Male Adolescents and Their Caregivers

Journal of Community Health

Volumn 42, Issue 3, 2017, Pages 522-532

  Johnson, Kristin L ^a,b   Lin, Meng Yun ^a   Cabral, Howard ^a   Kazis, Lewis E ^a   Katz, Ingrid T ^c,d,e  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHN SNOW INC   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adolescents; Gender; HPV vaccination; Secondary data

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; FEMALE; HUMAN; MALE; MIDDLE AGED; PARENT; PATIENT ATTITUDE; PSYCHOLOGY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VACCINATION;

ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; VACCINATION;

EID: 84992188221     PISSN: 00945145     EISSN: 15733610     Source Type: Journal    
DOI: 10.1007/s10900-016-0284-5     Document Type: Article

References (50)

1. Saslow, D., et al. (2007). American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. C CA: A Cancer Journal for Clinicians, 57(1), 7–28.
2. Markowitz, L. E., et al. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendations and Reports, 56(RR-2), 1–24.
3. Committee on Infectious Diseases. (2012). HPV vaccine recommendations. Pediatrics, 129(3), 602–605.
4. Centers for Disease Control and Prevention. (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 59(20), 626–629.
5. American College of Obstetricians and Gynecologists. (2010). Committee opinion no. 467: Human papillomavirus vaccination. Obstetrics & Gynecology, 116(3), 800–803.
6. Friedman, L., et al. (2011). Human papillomavirus vaccine: An updated position statement of the Society for Adolescent Health and Medicine. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 48(2), 215–216.
7. Statistics, N.C.f.H. (2013). Health, United States, 2013: With special feature on prescription drugs.
8. Centers for Disease Control and Prevention. (2013). National and state vaccination coverage among adolescents aged 13–17 years–United States, 2012. MMWR Morbidity and Mortality Weekly Report, 62(34), 685–93.
9. Stokley, S., et al. (2014). Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014—United States. MMWR Morbidity and Mortality Weekly Report, 63(29), 620–624.
10. Lu, P. J., et al. (2015). HPV vaccination coverage of male adolescents in the United States. Pediatrics, 136(5), 839–849.
11. Elam-Evans, L. D., Yankey, D., Jeyarajah, J., Singleton, J. A., Curtis, R. C., MacNeil, J., Hariri, S. (2014). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMWR Morbidity and Mortality Weekly Report, 63(29), 625–633.
12. Munoz, N., et al. (2010). Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Journal of the National Cancer Institute, 102(5), 325–339.
13. Cogliano, V., et al. (2005). Carcinogenicity of human papillomaviruses. The Lancet Oncology, 6(4), 204.
14. Dorell, C. G., et al. (2011). Human papillomavirus vaccination series initiation and completion, 2008–2009. Pediatrics, 128(5), 830–839.
15. Wang, E., et al. (2014). Nonmedical exemptions from school immunization requirements: A systematic review. American Journal of Public Health, 101, e1–e23.
16. Constable, C., Blank, N. R., & Caplan, A. L. (2014). Rising rates of vaccine exemptions: Problems with current policy and more promising remedies. Vaccine, 32(16), 1793–1797.
17. CDC.(2012). Vaccination coverage among children in kindergarten—United States, 2011–12 school year. MMWR. Morbidity and Mortality Weekly Report, 61(33), 647–652.
18. Parker Fiebelkorn, A., et al. (2010). Measles in the United States during the postelimination era. The Journal of Infectious Diseases, 202(10), 1520–1528.
19. Gastanaduy, P. A., et al. (2014). Measles—United States, January 1-May 23, 2014. MMWR. Morbidity and Mortality Weekly Report, 63(22), 496–499.
20. Atwell, J. E., et al. (2013). Nonmedical vaccine exemptions and pertussis in California, 2010. Pediatrics, 132(4), 624–630.
21. Omer, S. B., et al. (2009). Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. The New England Journal of Medicine, 360(19), 1981–1988.
22. Salmon, D. A., & Siegel, A. W. (2001). Religious and philosophical exemptions from vaccination requirements and lessons learned from conscientious objectors from conscription. Public Health Reports (Washington, D. C.: 1974), 116(4), 289–295.
23. Smith, P.J., et al. (2011). Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the Health Belief Model. Public Health Reports, 126(Suppl 2), 135–146.
24. Gaudino, J. A., & Robison, S. (2012). Risk factors associated with parents claiming personal-belief exemptions to school immunization requirements: Community and other influences on more skeptical parents in Oregon, 2006. Vaccine, 30(6), 1132–1142.
25. Cooper, L. Z., Larson, H. J., & Katz, S. L. (2008). Protecting public trust in immunization. Pediatrics, 122(1), 149–153.
26. Myers, E., et al. (2008). The current and future role of screening in the era of HPV vaccination. Gynecologic Oncology, 109(2 Suppl), S31–S39.
27. Oldach, B. R., & Katz, M. L. (2012). Ohio Appalachia public health department personnel: Human papillomavirus (HPV) vaccine availability, and acceptance and concerns among parents of male and female adolescents. Journal of Community Health, 37(6), 1157–1163.
28. Liddon, N. C., Hood, J. E., & Leichliter, J. S. (2012). Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: Findings from the 2006–2008 National Survey of Family Growth. Vaccine, 30(16), 2676–2682.
29. Zimmerman, R. K. (2006). Ethical analysis of HPV vaccine policy options. Vaccine, 24(22), 4812–4820.
30. Vamos, C. A., McDermott, R. J., & Daley, E. M. (2008). The HPV vaccine: Framing the arguments FOR and AGAINST mandatory vaccination of all middle school girls. The Journal of School Health, 78(6), 302–309.
31. Chicago, N.a.t.U.o. (2012). National immunization survey-teen: A user’s guide for the 2012 public-use data file, C.f.D.C.a. Prevention, Editor.
32. Dorell, C., Yankey, D., & Strasser, S. (2011). Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: Teen, 2009. Clinical Pediatrics, 50(12), 1116–1124.
33. Ojha, R. P., et al. (2013). The accuracy of human papillomavirus vaccination status based on adult proxy recall or household immunization records for adolescent females in the United States: Results from the National Immunization Survey-Teen. Annals of Epidemiology, 23(5), 281–285.
34. Katz, I. T., et al. (2010). Scaling up human papillomavirus vaccination: A conceptual framework of vaccine adherence. Sexual Health, 7(3), 279–286.
35. Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45(2–3), 107–114.
36. Holman, D. M., et al. (2014). Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature. JAMA Pediatrics, 168(1), 76–82.
37. Kessels, S. J., et al. (2012). Factors associated with HPV vaccine uptake in teenage girls: A systematic review. Vaccine, 30(24), 3546–3556.
38. CDC. (2012) Vaccines for children program. http://www.cdc.gov/vaccines/programs/vfc/index.html.
39. Gilkey, M. B., et al. (2015). Quality of physician communication about human papillomavirus vaccine: Findings from a national survey. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 24(11), 1673–1679.
40. Reiter, P. L., Katz, M. L., & Paskett, E. D. (2013). Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate. Vaccine, 31(31), 3121–3125.
41. Dorell, C., et al. (2013). Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010. Clinical Pediatrics, 52(2), 162–170.
42. Ylitalo, K. R., Lee, H., & Mehta, N. K. (2013). Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. American Journal of Public Health, 103(1), 164–169.
43. Jacobson, R. M., et al. (2016). The most effective and promising population health strategies to advance human papillomavirus vaccination. Expert Review Vaccines, 15(2), 257–269.
44. Tierney, C. D., et al. (2003). Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics, 112(5), 1076–1082.
45. Perkins, R. B., & Clark, J. A. (2012). Providers’ attitudes toward human papillomavirus vaccination in young men: Challenges for implementation of 2011 recommendations. American Journal of Men’s Health, 6(4), 320–323.
46. Kepka, D., et al. (2012). Human papillomavirus vaccine practices in the USA: Do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations? Sexually Transmitted Infections, 88(6), 433–435.
47. Gerend, M. A., Lee, S. C., & Shepherd, J. E. (2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34(7), 468–471.
48. Bingham, A., Drake, J. K., & LaMontagne, D. S. (2009). Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Archives of Pediatrics and Adolescent Medicine, 163(5), 455–461.
49. Conroy, K., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women’s Health (2002), 18(10), 1679–1686.
50. Zimet, G.D. (2006). Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Current Opinion in Obstetrics and Gynecology, 18(Suppl 1), s23–s28.